Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in infectious vaccine dealmaking
2.1. Introduction
2.2. Infectious vaccine deals over the years
2.3. Most active infectious vaccine dealmakers
2.4. Infectious vaccine deals by deal type
2.5. Infectious vaccine deals by therapy area
2.6. Infectious vaccine deals by industry sector
2.7. Deal terms for infectious vaccine deals
2.7.1 Infectious vaccine deals headline values
2.7.2 Infectious vaccine deal upfront payments
2.7.3 Infectious vaccine deal milestone payments
2.7.4 Infectious vaccine royalty rates

Chapter 3 – Leading infectious vaccine deals
3.1. Introduction
3.2. Top infectious vaccine deals by value

Chapter 4 – Most active infectious vaccine dealmakers
4.1. Introduction
4.2. Most active infectious vaccine dealmakers
4.3. Most active infectious vaccine deals company profiles

Chapter 5 – Infectious vaccine contracts dealmaking directory
5.1. Introduction
5.2. Infectious vaccine contracts dealmaking directory

Chapter 6 – Infectious vaccine dealmaking by technology type

Deal directory

Deal directory – Infectious vaccine deals by company A-Z
Deal directory – Infectious vaccine deals by deal type
Deal directory – Infectious vaccine deals by therapy area

Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

?
Table of figures

Figure 1: Infectious vaccine deals since 2016
Figure 2: Active infectious vaccine dealmaking activity – 2016 - 2023
Figure 3: Infectious vaccine deals by deal type since 2016
Figure 4: Infectious vaccine deals by therapy area since 2016
Figure 5: Infectious vaccine deals by industry sector since 2016
Figure 6: Infectious vaccine deals with a headline value
Figure 7: Infectious vaccine deals with an upfront value
Figure 8: Infectious vaccine deals with a milestone value
Figure 9: Infectious vaccine deals with a royalty rate value
Figure 10: Top infectious vaccine deals by value since 2016
Figure 11: Most active infectious vaccine dealmakers 2016 - 2023
Figure 12: Infectious vaccine deals by technology type since 2016